Preventive cardiologyMyocardial and Vascular Dysfunction and Exercise Capacity in the Metabolic Syndrome
Section snippets
Patient population
We recruited 410 subjects, most with cardiovascular risk factors (hypertension, diabetes mellitus, obesity), but without a previous history or clinical evidence of heart failure or coronary artery disease, who were undergoing risk factor management at the hospital (n = 332) or in the community (n = 78). The exclusion of 17 patients suspected to have organic heart disease or coronary heart disease on echocardiography and stress testing left a study group of 393 patients. The study patients
Clinical characteristics
MS, as defined by the National Cholesterol Education Program Adult Treatment Panel III criteria, was highly prevalent (44%) in our study population, who had no overt coronary artery disease or heart failure. Table 1 lists a number of the significant differences in the anthropometric and metabolic characteristics between patients with and without MS. The wider use of angiotensin-converting enzyme inhibitors, statins, and calcium channel blockers likely reflected the greater prevalence of
Discussion
The results of this study suggest that MS is an important predictor of subclinical myocardial dysfunction in patients without overt cardiovascular disease. Not only was the MS independently associated with subclinical dysfunction, but also the number of features of the MS was associated with the degree of myocardial dysfunction, reduced arterial compliance, and the degree of reduced cardiorespiratory fitness. Above all, these myocardial changes were independent predictors for exercise capacity.
References (27)
- et al.
Echocardiographic detection of early diabetic myocardial disease
J Am Coll Cardiol
(2003) - et al.
Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up
Am Heart J
(2001) - et al.
Noninvasive tests for arterial structure, function, and compliancedo they identify risk or diagnose disease?
J Am Soc Echocardiogr
(2004) - et al.
Correlation of intraabdominal fat accumulation and left ventricular performance in obesity
Am J Cardiol
(1989) - et al.
Coupled systolic-ventricular and vascular stiffening with ageimplications for pressure regulation and cardiac reserve in the elderly
J Am Coll Cardiol
(1998) - et al.
Cardiovascular morbidity and mortality associated with the metabolic syndrome
Diabetes Care
(2001) - et al.
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
JAMA
(2002) - et al.
Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men
Arch Intern Med
(2004) - et al.
Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults
Circulation
(2004) - et al.
Exercise capacity and mortality among men referred for exercise testing
N Engl J Med
(2002)
Obesity and the risk of heart failure
N Engl J Med
Increased pulse pressure and risk of heart failure in the elderly
JAMA
Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors
Curr Opin Nephrol Hypertens
Cited by (0)
This study was supported in part by a Centers of Clinical Research Excellence Award from the National Health and Medical Research Council, Canberra, Australia.